• All Products
      • Paperback
      • Hardcover
      • eBook
      • Audiobook

    By: Unknown

    Date Released

    Out of Print

    The discovery of TRAIL (TNF Related Apoptosis Inducing Ligand), also referred to as Apo-2, is in an era of intense research because TRAIL induces many cancer cells to undergo programmed cell death (apoptosis), while having no effect on normal cells. This important protein deserves extensive review at a formative time in the devlopement of our knowledge concerning its mechanism of action and the ways in which it can be used as a cancer chemotherapeutic agent. Consequently, this voume reviews the current status of research on TRAIL.

    Selected Contents:
    * Crystal Structure of RANK Ligand involved in bone metabolism
    * Promoter of TRAIL-R2 Gene
    * Monoclonal Antibodies against TRAIL
    * Modulation of TRAIL signaling complex
    * TRAIL in the airways
    * FLIP Protein and TRAIL-Induced Apoptosis
    * TRAIL and Ceramide
    * TRAIL and Viral Infection
    * TRAIL and Malignant Glioma

    You might also like

    Accepted Payments
    QBD Proudly Supports

    Need help? Call us on (07) 3291 7444